Skip to main content

Advertisement

Log in

Effects of smoking on the salivary and GCF levels of IL-17 and IL-35 in periodontitis

  • Original Article
  • Published:
Odontology Aims and scope Submit manuscript

Abstract

Periodontitis progression is associated with a host response in which anti-inflammatory and pro-inflammatory cytokine networks play a key role. Smoking is involved in the production of various mediators. The study aims to evaluate the levels of IL-17 and IL-35 in saliva and gingival crevicular fluid (GCF), to investigate the effects of smoking on these cytokines in smoker and non-smoker periodontitis patients. 19 smokers with periodontitis, 20 non-smokers with periodontitis, and 18 periodontally healthy subjects were included in the study. Periodontal clinical indexes were recorded and the levels of IL-17 and IL-35 in saliva and GCF were analyzed. No significant difference was detected among the groups in terms of salivary IL-17 and IL-35 levels. GCF IL-17 and IL-35 concentration levels in the non-smoker periodontitis group were significantly lower than the others (p < 0.05). Total levels of GCF IL-17 were significantly higher in both periodontitis groups than the control group; and total levels of GCF IL-35 were significantly higher in non-smoker periodontitis group than the others (p < 0.05). A positive correlation was detected between the salivary IL-17 and IL-35 levels (r = 0.884), GCF IL-17 and IL-35 concentrations (r = 0.854), and total GCF IL-17 and IL-35 (r = 0.973) levels (p < 0.01). The present study revealed a positive correlation between the IL-35 and IL-17 levels both in saliva and GCF. IL-17 and IL-35 can be considered as one of the cytokines that play a role in periodontal health and periodontitis; and smoking may be among the factors that affect the levels of these cytokines in GCF and saliva.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89:173–82.

    Article  Google Scholar 

  2. Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000. 2020;83(1):26–39.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton: CBC Press; 2008.

    Book  Google Scholar 

  4. Bergström J. Tobacco smoking and risk for periodontal disease. J Clin Periodontol. 2003;30(2):107–13.

    Article  PubMed  Google Scholar 

  5. Ramseier CA, Mirra D, Schütz C, et al. Bleeding on probing as it relates to smoking status in patients enrolled in supportive periodontal therapy for at least 5 years. J Clin Periodontol. 2015;42(2):150–9.

    Article  PubMed  Google Scholar 

  6. Qiu F, Liang C, Liu H, Zeng Y, Hou S, Huang S, et al. Impacts of cigarette smoking on immune responsiveness: up and down or upside down? Oncotarget. 2017;8(1):268–84.

    Article  PubMed  Google Scholar 

  7. Zhang J, An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27–37.

    Article  MathSciNet  PubMed  PubMed Central  CAS  Google Scholar 

  8. Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: Driving protection and pathology. Eur J Immunol. 2017;47(4):607–14.

    Article  PubMed  CAS  Google Scholar 

  9. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566–9.

    Article  ADS  PubMed  CAS  Google Scholar 

  10. Niedbala W, Wei X, Cai B, Hueber AJ, Leung BP, McInnes IB, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 2007;37(11):3021–9.

    Article  PubMed  CAS  Google Scholar 

  11. Silness J, Löe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22(1):121–35.

    Article  PubMed  CAS  Google Scholar 

  12. Löe H, Silness J. Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontol Scand. 1963;21(6):533–51.

    Article  PubMed  Google Scholar 

  13. Kuru L, Griffiths GS, Petrie A, Olsen I. Changes in transforming growth factor-β1 in gingival crevicular fluid following periodontal surgery. J Clin Periodontol. 2004;31(7):527–33.

    Article  PubMed  CAS  Google Scholar 

  14. Buduneli N, Buduneli E, Kütükçüler N. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol. 2009;80(8):1274–80.

    Article  PubMed  CAS  Google Scholar 

  15. Al-Shammari KF, Al-Khabbaz AK, Al-Ansari JM, Neiva R, Wang H. Risk indicators for tooth loss due to periodontal disease. J Periodontol. 2005;76(11):1910–8.

    Article  PubMed  Google Scholar 

  16. Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015;69(1):142–59.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schmidlin PR, Dehghannejad M, Fakheran O. Interleukin-35 pathobiology in periodontal disease: a systematic scoping review. BMC Oral Health. 2021;21(1):1–9.

    Article  Google Scholar 

  18. Teymouri M, Pirro M, Fallarino F, Gargaro M, Sahebkar A. IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases. Int J Cancer. 2018;143(9):2105–15.

    Article  PubMed  CAS  Google Scholar 

  19. Okada K, Fujimura T, Kikuchi T, Aino M, Kamiya Y, Izawa A, et al. Effect of interleukin (IL)-35 on IL-17 expression and production by human CD4+ T cells. PeerJ. 2017;5: e2999.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Inönü E, Kayis SA, Eskan MA, Hakki SS. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease. J Periodont Res. 2020;55(4):511–8.

    Article  Google Scholar 

  21. Apatzidou DA, Iskas A, Konstantinidis A, Alghamdi AM, Tumelty M, Lappin DF, et al. Clinical associations between acetylcholine levels and cholinesterase activity in saliva and gingival crevicular fluid and periodontal diseases. J Clin Periodontol. 2018;45(10):1173–83.

    Article  PubMed  CAS  Google Scholar 

  22. Özçaka Ö, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodont Res. 2011;46(5):592–8.

    Google Scholar 

  23. Prakasam S, Srinivasan M. Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis. 2014;20(2):171–7.

    Article  PubMed  CAS  Google Scholar 

  24. Batool H, Nadeem A, Kashif M, Shahzad F, Tahir R, Afzal N. Salivary levels of IL-6 and IL-17 could be an indicator of disease severity in patients with calculus associated chronic periodontitis. Biomed Res Int. 2018;18(Feb):8531961.

    Google Scholar 

  25. Javed F, Al-Zawawi AS, Allemailem KS, Almatroudi A, Mehmood A, Divakar DD, et al. Periodontal conditions and whole salivary IL-17A and-23 levels among young adult cannabis sativa (marijuana)-smokers, heavy cigarette-smokers and non-smokers. Int J Environ Res Public Health. 2020;17(20):7435.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Kanmaz B, Lappin DF, Nile CJ, Buduneli N. Effects of smoking on non-surgical periodontal therapy in patients with periodontitis Stage III or IV, and Grade C. J Periodontol. 2020;91(4):442–53.

    Article  PubMed  Google Scholar 

  27. Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res. 2007;86(4):347–51.

    Article  PubMed  CAS  Google Scholar 

  28. Johnson R, Wood N, Serio F. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol. 2004;75(1):37–43.

    Article  PubMed  CAS  Google Scholar 

  29. Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gamonal J. Levels of interleukin 17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol. 2005;32(4):383–9.

    Article  PubMed  Google Scholar 

  30. Cifcibasi E, Koyuncuoglu C, Ciblak M, Badur S, Kasali K, Firatli E, et al. Evaluation of local and systemic levels of interleukin-17, interleukin-23, and myeloperoxidase in response to periodontal therapy in patients with generalized aggressive periodontitis. Inflammation. 2015;38(5):1959–68.

    Article  PubMed  CAS  Google Scholar 

  31. Sadeghi R, Sattari M, Dehghan F, Akbari S. Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitis. Cent Eur J Immunol. 2018;43(1):76–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol. 2005;32(4):369–74.

    Article  PubMed  CAS  Google Scholar 

  33. Lütfioğlu M, Sakallıoğlu U, Sakallıoğlu EE, Özden FO, Ürkmez SS, Bilgici B. Effects of smoking on the gingival crevicular fluid levels of interleukin-17A, interleukin-17E, and oxidative stress following periodontal treatment process. J Periodont Res. 2021;56(2):388–96.

    Article  Google Scholar 

  34. Cafferata EA, Terraza-Aguirre C, Barrera R, et al. Interleukin-35 inhibits alveolar bone resorption by modulating the Th17/Treg imbalance during periodontitis. J Clin Periodontol. 2020;47(6):676–88.

    Article  PubMed  CAS  Google Scholar 

  35. Köseoğlu S, Sağlam M, Pekbağrıyanık T, Savran L, Sütçü R. Level of interleukin-35 in gingival crevicular fluid, saliva, and plasma in periodontal disease and health. J Periodontol. 2015;86(8):964–71.

    Article  PubMed  Google Scholar 

  36. Kalburgi NB, Muley A, Shivaprasad BM, Koregol AC. Expression profile of IL-35 mRNA in gingiva of chronic periodontitis and aggressive periodontitis patients: a semiquantitative RT-PCR study. Dis Markers. 2013;35(6):819–23.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Raj SC, Panda SM, Dash M, Patnaik K, Mohanty D, Katti N, et al. Association of human interleukin-35 level in gingival crevicular fluid and serum in periodontal health, disease, and after nonsurgical therapy: a comparative study. Contemp Clin Dent. 2018;9(2):293–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Mitani A, Niedbala W, Fujimura T, Mogi M, Miyamae S, Higuchi N, et al. Increased expression of interleukin (IL) 35 and IL 17, but not IL 27, in gingival tissues with chronic periodontitis. J Periodontol. 2015;86(2):301–9.

    Article  PubMed  Google Scholar 

  39. Bai J, Qiu S, Zhong X, Huang Q, He Z, Zhang J, et al. Erythromycin enhances regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediat Inflamm. 2012;2012:410232

    Article  Google Scholar 

  40. Costantini E, Sinjari B, Piscopo F, Porreca A, Reale M, Caputi S, et al. Evaluation of salivary cytokines and Vitamin D levels in periodontopathic patients. Int J Mol Sci. 2020;21(8):2669.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Choi J, Leung PSC, Bowlus C, Gershwin ME. IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol. 2015;49(3):327–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was financially supported by the Scientific Research Foundation of Gazi University (Grant number: “03/2019-07”).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: GT, EST, AAY, MY. Formal Analysis: EST, GT. Investigation: EST, GT, AAY, MY. Methodology: GT, EST, AAY, MY. Project Administration: GT, EST, AAY, MY. Writing—Original Draft: EST, GT. Writing—Review and Editing: EST, GT, AAY, MY.

Corresponding author

Correspondence to Gulay Tuter.

Ethics declarations

Conflict of interest

The authors declare that they have no potential conflicts of interest in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taskaldiran, E.S., Tuter, G., Yucel, A.A. et al. Effects of smoking on the salivary and GCF levels of IL-17 and IL-35 in periodontitis. Odontology 112, 616–623 (2024). https://doi.org/10.1007/s10266-023-00843-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10266-023-00843-8

Keywords

Navigation